evidencegaps
Primary study · included by 1 review

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma.

He 2022 · He Wenwu, Leng Xuefeng, Mao Tianqin, et al. · The oncologist · 2022

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as He 2022 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.